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INTRODUCTION
Colorectal cancer is the third most common cancer
worldwide (1). In Spain it is the second leading cause of
death due to cancer (2). In our country it is estimated that
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RESUMEN
Objetivo: en el cáncer colorrectal son poco conocidas las cau-
sas del frecuente desarrollo de lesiones neoplásicas sincrónicas.
Pretendemos identificar posibles factores que pudieran influir en
la multicentricidad lesional. Su conocimiento sería útil para, tras el
tratamiento de las lesiones iniciales, optimizar el seguimiento en
los pacientes que los presentaran.
Pacientes y métodos: estudiamos retrospectivamente 382
cánceres colorrectales diagnosticados mediante colonoscopia
completa y estudio de la pieza quirúrgica. Comparamos una serie
de parámetros referentes a los antecedentes personales y familia-
res, hábitos, datos clínicos y del tumor entre los grupos con y sin
lesiones neoplásicas sincrónicas, mediante análisis estadístico uni-
variable y multivariable.
Resultados: doscientos ocho (54,5%) pacientes presentaron
adenomas sincrónicos y 28 (7,3%) carcinoma sincrónico. En el aná-
lisis multivariable el sexo masculino: OR = 1,97; IC = 1,13-3,45,
p = 0,017; la edad superior a 59 años: OR = 2,57; IC = 1,54-4,29,
p < 0,001; el antecedente personal de pólipo colónico: OR = 3,04,
IC = 1,04-8,85, p = 0,042 y el carácter obstructivo del cáncer:
OR = 0,48; IC = 0,27-0,85, p = 0,012 se asocian significativamen-
te con la multicentricidad lesional.
Conclusión: en los enfermos con cáncer colorrectal, nuestro
estudio muestra una serie de parámetros, de fácil determinación,
que podrían comportarse como factores de riesgo para el desarro-
llo de multicentricidad lesional. Estos factores deberán confirmar-
se mediante un estudio de seguimiento, analizando su comporta-
miento entre los pacientes que presenten o no lesiones
metacrónicas tras la limpieza quirúrgico-endoscópica inicial.
Palabras clave: Cáncer colorrectal. Lesiones sincrónicas. Facto-
res de riesgo.
ABSTRACT
Aim: few data have been published regarding the causes of
synchronous lesions in patients with colorectal cancer. The aim of
our study was to identify potential factors that might be implicated
in the development of multicentric lesions, since this knowledge
could be useful for tailored follow-up once initial synchronous le-
sions have been removed.
Methods: we retrospectively reviewed 382 colorectal cancer
cases diagnosed by total colonoscopy and histological study of
surgical specimens. We divided our population into 2 groups,
based on whether they had synchronous lesions or otherwise.
Several data related to personal and family history, habits, symp-
toms, and tumor characteristics were assessed. Univariate and
multivariate statistical analyses were performed.
Results: 208 (54.5%) patients had synchronous adenomas
and 28 (7.3%) had synchronous cancer. A multivariate analysis
showed that the following parameters were consistently related
to the presence of multicentric lesions –male gender: OR = 1.97;
CI = 1.13-3.45; p = 0.017; age ≥ 59 years: OR = 2.57;
CI = 1.54-4.29; p < 0.001; personal history of colonic adeno-
mas: OR = 3.04; CI = 1.04-8.85; p = 0.042; and obstructive tu-
mors: OR = 0.48; CI = 0.27-0.85; p = 0.012.
Conclusion: our results show that several parameters that are
easy to measure could be considered risk factors for the develop-
ment of multicentric lesions. These factors need to be confirmed
with follow-up studies analyzing their role in patients with and
without metachronic lesions once all synchronous lesions have
been removed.
Key words: Colorectal cancer. Synchronous lesions. Risk factors.
there are 25,000 new diagnoses and 12,500 deaths/year
(2). A great majority of colorectal cancers develop from a
pre-existing adenoma, following a multi-step adenoma-
carcinoma sequence (1-13), and as a rule synchronous
neoplastic lesions, adenomas, and less frequently carci-
nomas are present when the tumor is diagnosed (14-17).
It has been postulated that tumoral multicentricity may be
due to an interaction of numerous factors, which might
include a particular predisposition, both personal and fa-
miliar, environmental causes, and/or tumor characteris-
tics, which increase the likelihood of developing neo-
plasms in different colonic segments (18,19).
There are currently several publications concerning
the risk of synchronous lesions developing in patients
with colorectal adenoma (15,16,20-23), but we were only
able to find one study referring to the identification of
possible risk factors for the development of synchronous
neoplastic lesions in colorectal cancer (14). Identifying
differences amongst colorectal cancer series, both with
and without synchronous lesions, could define some pos-
sible risk factors for tumoral multicentricity. Colorectal
cancer surveillance is currently a matter of debate (3,24-
31). The identification of possible multicentricity factors
could facilitate a more rational monitorization for the
screening of metachronous lesions following initial endo-
scopic-surgical cleansing procedures. Finally, it would
facilitate a practical approach to the theoretical possibili-
ty of selecting patient subgroups, which in the future
could benefit from chemoprevention treatments, with the
aim of avoiding lesion recurrence (32-35).
MATERIALAND METHODS
Colorectal cancers diagnosed between 1999 and 2003 at
Clínica Universitaria de Navarra and Hospital de Navarra
by total preoperative colonoscopy or total colonoscopy
within 3 months after surgery were included. In all cases
tumors were removed and confirmed histologically. All
pathological studies were reviewed by a single pathologist
in order to ensure that the same criteria were used, and to
avoid inter-observer differences. Colorectal cancers occur-
ring in the context of multiple familial polyposis or inflam-
matory intestinal disease were excluded.
The presence of a second colorectal carcinoma, adeno-
matous polyps, tubular and/or villous polyps, and serrated
adenomas was considered a synchronous neoplastic lesion,
and hyperplastic polyps were not included in our study.
In patients with two or more tumors the lesion with a
lower tumoral stage was labeled as synchronous cancer.
We also considered malignized polyps with any areas of
in situ carcinoma as synchronous cancer.
Our series was divided into two groups depending on
whether they presented synchronous neoplastic lesions
when colorectal cancer was diagnosed. We studied the
possible differences between both groups with respect to
the following parameters: a) Age: We analyzed this vari-
able using continuous values and in patients over and un-
der 60 years of age; b) Gender; c) Regular place of resi-
dence: In Navarre or any other Spanish Autonomous Com-
munity; d) Body mass index (BMI), using the WHO
classification system (36) to classify patients as under-
weight: BMI < 21; normal weight: 21-24.9; overweight:
25-29.9; and obese: > 30. We compared the incidence of
cases with and without synchronous lesions for the follow-
ing BMI cut-off points: < 21, < 25 and ≥ 30; e) Tobacco:
Like other authors (37-39), we considered patients who
had smoked 7 or more cigarettes weekly for at least a year
prior to the diagnosis as smokers, and ex-smokers were pa-
tients who had not smoked for at least one year. Both
groups were analyzed as to whether patients were smokers
or nonsmokers, and number of cigarettes smoked, estab-
lishing cut-off points as ≥ 20, ≥ 15, ≥ 10 and ≥ 5 ciga-
rettes/day; f) Alcohol: Non-drinkers, drinkers who con-
sumed less than 40 grams and over 40 grams of
ethanol/day, evaluating patients overall and according to
their gender; g) Patient medical history of: Colorectal can-
cer or cancer of any organ, previous history of adenoma-
tous colon polyps; h) History of cancer in first-degree fam-
ily members. All these medical history factors were
considered dichotomously: Yes/no responses, in accor-
dance with clinical record data and/or a posted question-
naire; i) Revised Bethesda criteria (40), with cases fulfill-
ing at least 1 of all 5 criteria being considered positive; j)
Predominant clinical symptom, based on the reason for di-
agnostic colonoscopy and using the following classifica-
tion system: i) Personal or family history of polyps or col-
orectal cancer; ii) Check-up of asymptomatic patient; iii)
Rectal bleeding; iv) Abdominal pain; v) Altered bowel
movements, constipation or diarrhea; vi) Anemia; vii)
Other; k) Cleaning achieved during the diagnostic
colonoscopy: i) Good: Correct visualization of the mucosa;
ii) Acceptable: Aspirable liquid contents permitting ade-
quate examination of the mucosa; and iii) Poor: Colon
contents are solid or liquid but cannot be aspirated, making
an adequate examination of the mucosa difficult or not fea-
sible; l) Location of colorectal cancer: Rectum, sigmoid,
descending, transverse, and ascending-cecum colon; m)
Obstructive nature of the colorectal cancer: Cancer which
blocks the passage of the endoscope, avoiding cecum intu-
bation; n) Histological classification of the cancer: To fa-
cilitate the statistical study cancers were grouped into ade-
nocarcinomas and other tumors; o) Grade of tumor
differentiation (41): Well differentiated, moderately differ-
entiated, and undifferentiated; and p) Tumor staging using
the American Joint Comittee on Cancer pTNM classifica-
tion (5th edition) (42). For this statistical study stages 0 and
I were placed in the same group.
Statistical analysis
The results are expressed as mean ± standard deviation
when variables displayed a normal distribution pattern
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using the Kolmogorov-Smirnoff test, and as the median
value and range in the remaining cases. Categorical vari-
ables are expressed as frequencies and percentages.
The quantitative variables showing normal distribution
patterns were compared using Student’s t-test. Otherwise
the Mann-Whitney U test was employed. Qualitative
variables were compared by means of the Chi square and
Fisher’s exact tests, with odds ratio (OR) and 95% confi-
dence interval (CI) determination. Values of p < 0.05
were regarded statistically significant.
Multivariate analysis
A multivariate analysis was performed using a multi-
ple logistic regression analysis, the dependent variable
being the presence or absence of synchronous lesions,
and independent variables being those which exhibited a
p < 0.20 value in the univariate study. Interactions were
tested by introducing the sum of variables into the model.
RESULTS
In all 382 patients with colorectal cancer were ana-
lyzed, 65.2% of which were males and 34.8% females.
Median age was 65 years (range = 20-88). The presence
of synchronous tumors was confirmed in 28 patients
(7.3% of the entire population), all of them with synchro-
nous adenomas. At least one synchronous adenoma was
diagnosed in 208 patients (54.5% of total). No significant
differences were identified with regard to colon cleansing
between groups with and without synchronous neoplastic
lesions in the diagnostic endoscopy: Good preparation =
68.6 vs. 70.5%, acceptable preparation = 17.3 vs. 22.3%,
and poor preparation = 14.1 vs. 7.25% (p = 0.46).
Median age in the group with synchronous lesions (67,
range 30-83) was significantly higher than in patients
without polyps (60, range 20-88; p < 0.001). Table I
shows the differences between colorectal cancers, with
and without synchronous neoplastic lesions, with respect
to patient age (under or over 60 years), gender, regular
place of residence, medical history of colon polyps, col-
orectal or any other type of cancer, medical history of
cancer in first-degree family members, and revised
Bethesda criteria. A higher frequency of synchronous
adenomas in the ≥ 60-year group was confirmed: 64 vs.
37%, OR = 3.02; 95% CI: 1.91-4.78; p < 0.000001. Syn-
chronous lesions were significantly more frequent in
males (62.7%) compared to females (39.1%), OR = 2.61;
CI = 1.66-4.12; p < 0.0001. Patients with a medical histo-
ry of colon polyps had a greater tendency to have syn-
chronous lesions (68 vs. 48.8%), but this difference was
not statistically significant (p = 0.10).
The links between tobacco consumption, alcohol con-
sumption, and body mass index and synchronous lesion
frequency are shown in table II. Toxic habits mainly af-
fected males, 80.8% of whom were smokers, 88.5%
drinkers, and 84.4% both smokers and drinkers. We
recorded a higher proportion of synchronous lesions in
cases of patients who actively smoked and/or had
smoked, and this difference was almost statistically sig-
nificant (smokers vs. non-smokers: p = 0.07); smokers
and ex-smokers vs. non-smokers: p = 0.098. Patients with
synchronous lesions more often consumed 10 or more
cigarettes/day: 29/207 (14%) vs. 14/175 (8%), p = 0.064.
The other cut-off points studied showed smaller differ-
ences between these two groups: ≥ 20 cigarettes/day: p =
0.15; ≥ 15: p = 0.17; and ≥ 5 cigarettes/day: p = 0.094.
Forty-seven percent of patients consumed alcohol, but
only 4% of cancer patients consumed over 40 grams of
ethanol/day, so our statistical analysis made a distinction
between drinkers and non-drinkers, without specifying
cut-off points for alcohol consumption. A significantly
higher incidence of drinkers was observed in the series
with synchronous lesions: p = 0.006; OR = 1.86; CI 95%:
1.16-2.99. When groups were divided on the basis of
gender, differences were reduced in males: p = 0.058; and
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Table I. Personal and familial factors, and synchronous lesion rate
No synchronous Synchronous p
lesions lesions
n % n %
Age
≥ 60 years 89/247 36 158/247 34 < 0.000001
< 60 years 85/135 65.4 50/135 34.6
Gender
Male 93/249 37.3 156/249 62.7 < 0.001
Female 81/133 60.9 52/133 39.1
Place of residence
Navarre 92/174 52.9 109/208 52.4 0.93
Other 82/174 47.1 99/208 47.6
History of adenomatous polyps 144/295 48.8 17/25 68 0.10
Personal history of CRC 4/173 2.3 7/208 3.4 0.46
Personal history of other tumors 10/173 5.8 17/207 8.2 0.57
History of cancer in first-degree family members 82/146 56.2 83/170 48.8 0.53
Revised Bethesda criteria (at least one criteria) 64/131 48.9 86/195 44.1 0.40
these differences were statistically eliminated in females:
p = 0.43.
A BMI < 21 was recorded in 3.9%, and 58.3% of these
patients were female. The group with synchronous lesions
showed a lower incidence of patients with BMI < 21: 1.9%
as opposed to 6.2%, p = 0.09, with no significant differ-
ences between BMI cut-off points ≥ 30 and < 25.
The clinical symptoms which prompted the diagnostic
colonoscopy were very similar for the series with and
without synchronous lesions (p = 0.99) (Table II).
Regarding cancer-dependent factors, we noted that in
cases with obstructive carcinoma the incidence of adeno-
mas was 34/88 (38.6%), which was significantly lower
than in cases of non-obstructive cancer: 173/293 (59%);
p < 0.001; OR = 0.44; CI: 0.26-0.73.
We did not detect significant differences (p = 0.21) in
cancer-involved anatomical colonic segment and pres-
ence or absence of synchronous lesions, or histological
type of tumor and grade of differentiation (Table III).
Tumor staging (pTNM) was similar for groups with
and without synchronous lesions (p = 0.79) (Fig. 1).
Multivariate statistical analysis
The results for the multivariate logistic regression
analysis model are shown in table IV. Being over 59
years of age, being male, and having a medical history of
colon polyps are factors associated with a higher frequen-
cy of synchronous lesions, and obstructive cancer is asso-
ciated with a lower risk of associated adenomas. BMI and
tobacco consumption do not show significant differences
between groups with and without synchronous lesions.
Alcohol, although having no significant association with
synchronous lesions (p = 0.19), adjusts the effect of sex
on the frequency of these lesions.
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Table II. Tobacco, alcohol, body mass index, symptoms, and synchronous lesion rate
No synchronous Synchronous p
lesions lesions
n % n %
Tobacco
No smoker 91/164 55.5 91/197 46.2 0.14
Ex-smoker 47/174 28.7 61/197 31
Smoker 26/164 15.8 45/197 22.8
Alcohol (global)
Non-drinkers 89/145 61.4 81/176 46 0.006
Drinkers 56/145 38.6 95/176 54
Alcohol (males)
Non-drinkers 36/81 44.4 41/131 31.3 0.058
Drinkers 45/81 55.6 90/131 68.7
Alcohol (females)
Non-drinkers 55/69 79.7 41/48 85.4 0.43
Drinkers 14/69 20.3 7/48 14.6
Body mass index
< 21 9/174 5.2 3/208 1.4 0.036
< 25 52/174 29.9 47/208 22.6 0.094
≥ 30 29/129 22.5 29/143 20.3 0.66
Predominant symptom
Rectal bleeding 92/173 53.2 113/207 54.6 0.99
Anemia 27/173 15.6 29/207 14
Change bowel movements 20/173 11.6 24/207 11.6
Abdominal pain 16/173 9.2 18/207 6.7
Check-up 8/173 4.6 10/207 4.8
History of colonic lesion 5/173 2.9 8/207 3.9
Others 5/173 2.9 5/207 2.4
Table III. Location, histological classification, differentiation
grade, and synchronous lesion rate
No synchronous Synchronous p
lesions lesions
n % n %
Location 0.21
Rectum 79 48.2 77 37
Sigma 35 21.3 62 29.8
Descending 8 4.9 12 5.8
Transverse 13 7.9 17 8.2
Ascending-cecum 39 23.7 40 19.2
Histological classification 0.31
Adenocarcinoma 151 87.8 173 83.6
Other 21 12.2 34 16.4
Differentation grade 0.44
Well 26 26.8 37 19.3
Moderately 102 65.8 132 68.7
Undifferentiated 27 17.4 23 12
DISCUSSION
The lack of bibliographical references concerning fac-
tors which could produce lesional multicentricity in pa-
tients with colorectal cancer was mentioned above (14).
The identification of readily accessible factors (clinical,
personal or familial factors, or specific tumor characteris-
tics) which might influence the multiplicity of lesions
would be an important step to permit the identification of
a subgroup of patients who would require closer monitor-
ization after tumor resection and endoscopic polyp
cleansing procedures (14). Hypothetically, this subgroup
of patients with a greater tendency to present lesional
multicentricity could even constitute a target population
for chemoprevention therapies such as acetylsalicylic
acid or COX-2 inhibitors, which are currently under in-
vestigation (32-35), in order to avoid or reduce the risk of
continuing to present new colon neoplastic lesions. Our
study aims to identify possible risk factors for the devel-
opment of synchronous lesions by analyzing the frequen-
cy of these possible risk factors in two colorectal cancer
groups, with and without synchronous neoplastic lesions.
As this is a retrospective study, we have had to con-
tend with the limitations imposed by a lack of certain
data, which are insufficiently detailed in the clinical
records and essentially refer to the familial and personal
medical history of cancer patients and their toxic habits.
We have tried to make up for this by sending patients a
questionnaire. Nevertheless, as this limitation affects
both groups, with and without synchronous lesions, in
our opinion this has not caused any significant bias in our
evaluation of results.
As in the only bibliographical reference we came across
(14), in patients with colorectal cancer being male and
having a history of colon adenomas is associated with a
significantly higher incidence of synchronous neoplastic
lesions, which appears to indicate that this is a risk factor
for their occurrence. These factors have already been pos-
tulated to favor multicentricity in patients with colon ade-
nomas who have not developed cancer (15,16,20,43). On
the other hand, in our study we were unable to confirm the
possible influence of other parameters such as a family his-
tory of gastric cancer or specific characteristics of the tu-
mor, for example proximal localization, mucinous histo-
logical type, or T II staging, which, in the series by Piñol
are described as linked to lesional multicentricity (14).
As would be expected, greater age is associated with a
higher incidence of synchronous lesions, which has already
been reported in series of patients with adenomas (15,16).
It has been reported that both tobacco and alcohol de-
pendency increase the risk of developing neoplastic le-
sions of the colon (44-52), even at a very young age (44),
and the possible effect of alcohol and tobacco on the sta-
bility system of microsatellites is a matter of debate (53-
57). Similarly, it has been demonstrated that patients who
smoke have a higher risk of new adenomas after endo-
scopic polypectomy (58). In the univariate analysis to-
bacco and alcohol consumption were more common in
patients with synchronous lesions, but both habits were
associated with the male sex. In the multivariate analysis
neither tobacco nor alcohol showed any significant associ-
ation with synchronous lesions. When alcohol is intro-
duced into the model, the effect of gender on the frequency
of synchronous lesions is adjusted, which confirms that al-
cohol is a confounding factor and that the male gender is a
risk factor for the development of synchronous lesions.
It has been postulated that an increase in BMI may fa-
vor the development of colorectal adenomas and carcino-
mas (59-63). In the univariate analysis thinness, ex-
pressed as BMI < 21, appears to act as a protective factor
against the presence of synchronous lesions. In the multi-
variate analysis no significant differences were observed,
possibly owing to the small number of underweight pa-
tients and an association with the female sex.
Finally, our cases of colorectal cancer with an obstruc-
tive pattern showed a lower incidence of synchronous le-
sions. We can provide no logical explanation for this
finding, given that in our bibliographical search the inci-
dence of synchronous lesions in this type of neoplasm
ranges from 36 to 58% (64,65), which is no less than for
other cancers (64).
In summary, in patients with colorectal cancer our
study has shown a series of variables very easy to obtain:
Male gender, advanced age, medical history of colon
polyps, and non-obstructive nature of the tumor, which
could act as risk factors for the development of lesional
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Fig. 1. CRC staging and synchronous lesions.
Table IV. Results for the multivariate analysis model
Parameters p Odds ratio 95% CI
Male gender 0.017 1.97 (1.13-3.45)
Age ≤ 60 years < 0.01 2.57 (1.54-4.29)
Alcohol 0.196 1.42 (0.84-2.41)
History of adenomatous polyps 0.042 3.04 (1.04-8.85)
Obstructive colorectal cancer 0.012 0.48 (0.27-0.85)
multicentricity, defining a subgroup of patients who will
require closer post-surgical monitoring. These possible
risk factors should be confirmed in a follow-up study af-
ter surgical-endoscopic cleansing of initial lesions, ana-
lyzing their behavior in patients who present or fail to
present with metachronous lesions. This research is cur-
rently underway.
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